DAT, deacylating autotransporter toxin, from


Journal

Proceedings of the National Academy of Sciences of the United States of America
ISSN: 1091-6490
Titre abrégé: Proc Natl Acad Sci U S A
Pays: United States
ID NLM: 7505876

Informations de publication

Date de publication:
03 10 2023
Historique:
medline: 27 9 2023
pubmed: 25 9 2023
entrez: 25 9 2023
Statut: ppublish

Résumé

The pathogenic bacteria

Identifiants

pubmed: 37748060
doi: 10.1073/pnas.2308260120
pmc: PMC10556565
doi:

Substances chimiques

Type V Secretion Systems 0
Lipid A 0
Lipopolysaccharides 0
Pertussis Toxin EC 2.4.2.31
Toxins, Biological 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e2308260120

Références

J Bacteriol. 1987 Jun;169(6):2847-53
pubmed: 3584073
J Biol Chem. 1986 Jun 25;261(18):8182-91
pubmed: 3087970
Biochem J. 2013 Sep 15;454(3):515-23
pubmed: 23841650
Future Microbiol. 2010 Jul;5(7):1005-13
pubmed: 20632801
Rev Infect Dis. 1979 May-Jun;1(3):401-12
pubmed: 233166
Biochem Biophys Res Commun. 2014 Mar 7;445(2):439-44
pubmed: 24530907
Sci Adv. 2022 Dec 21;8(51):eade8971
pubmed: 36542710
Nat Biotechnol. 2003 Jul;21(7):807-12
pubmed: 12808462
Appl Environ Microbiol. 2003 Jul;69(7):3901-10
pubmed: 12839759
Mol Interv. 2002 Jun;2(3):168-84
pubmed: 14993377
Infect Immun. 1993 Feb;61(2):486-90
pubmed: 8423077
Mol Cell. 2015 Apr 2;58(1):110-22
pubmed: 25773595
J Am Chem Soc. 2009 Apr 8;131(13):4967-75
pubmed: 19281244
Mol Pharmacol. 1988 Sep;34(3):279-85
pubmed: 2843748
Proc Natl Acad Sci U S A. 2003 Dec 23;100(26):16077-82
pubmed: 14673086
Annu Rev Microbiol. 2007;61:89-112
pubmed: 17506669
PLoS Pathog. 2017 Dec 7;13(12):e1006669
pubmed: 29216326
Microbiol Immunol. 2023 Jun;67(6):314-317
pubmed: 36976834
Nature. 1960 Feb 20;185(4712):537-8
pubmed: 18988331
mBio. 2022 Apr 26;13(2):e0319721
pubmed: 35357202
Sci Signal. 2008 Jun 24;1(25):re5
pubmed: 18577758
Infect Immun. 2014 Feb;82(2):773-82
pubmed: 24478091
Nat Biotechnol. 2022 Jul;40(7):1023-1025
pubmed: 34980915
Clin Infect Dis. 2015 Nov 1;61(9):1421-31
pubmed: 26113655
mSphere. 2021 Oct 27;6(5):e0081921
pubmed: 34643424
Int J Med Microbiol. 2011 Aug;301(6):461-8
pubmed: 21616712
Curr Biol. 1995 Feb 1;5(2):107-9
pubmed: 7743169
Exp Brain Res. 2009 Jun;196(1):53-65
pubmed: 19396590
Nat Methods. 2012 Jun 28;9(7):676-82
pubmed: 22743772
Clin Microbiol Rev. 2005 Apr;18(2):326-82
pubmed: 15831828
Biol Pharm Bull. 2012;35(12):2103-11
pubmed: 23207763
BMC Genomics. 2012 Oct 10;13:545
pubmed: 23051057
Vaccine. 1998 Oct;16(17):1595-603
pubmed: 9713934
Gut Microbes. 2011 Jan-Feb;2(1):13-24
pubmed: 21637014
PLoS One. 2021 Jan 25;16(1):e0245197
pubmed: 33493164
Clin Infect Dis. 2012 Feb 15;54(4):534-7
pubmed: 22156857
Infect Immun. 2008 Jul;76(7):2966-77
pubmed: 18426869
J Biol Chem. 1998 Oct 2;273(40):25831-9
pubmed: 9748257
Trends Biochem Sci. 1995 May;20(5):178-9
pubmed: 7610479
Pediatr Infect Dis J. 1994 Apr;13(4):306-9
pubmed: 8036048
Membranes (Basel). 2021 Mar 20;11(3):
pubmed: 33804791
Nucleic Acids Res. 2021 Jan 8;49(D1):D412-D419
pubmed: 33125078
Future Microbiol. 2010 Aug;5(8):1185-201
pubmed: 20722598
BMC Genomics. 2016 Sep 30;17(1):767
pubmed: 27716057
Infect Immun. 2005 Oct;73(10):6249-59
pubmed: 16177296
Proc Natl Acad Sci U S A. 2014 Jan 14;111(2):787-92
pubmed: 24277828
Vaccine. 2004 May 7;22(15-16):1892-8
pubmed: 15121300
Pathog Dis. 2016 Oct;74(7):
pubmed: 27609461
Nat Rev Microbiol. 2014 Apr;12(4):274-88
pubmed: 24608338
Infect Immun. 1994 Aug;62(8):3381-90
pubmed: 8039908
Biochemistry. 2003 Jul 8;42(26):7931-41
pubmed: 12834345
mSphere. 2019 Apr 24;4(2):
pubmed: 31019000

Auteurs

Yukihiro Hiramatsu (Y)

Department of Molecular Bacteriology, Research Institute for Microbial Diseases, Osaka University, Suita, Osaka 565-0871, Japan.

Takashi Nishida (T)

Department of Molecular Bacteriology, Research Institute for Microbial Diseases, Osaka University, Suita, Osaka 565-0871, Japan.

Natsuko Ota (N)

Department of Molecular Bacteriology, Research Institute for Microbial Diseases, Osaka University, Suita, Osaka 565-0871, Japan.

Yuki Tamaki (Y)

Department of Molecular Bacteriology, Research Institute for Microbial Diseases, Osaka University, Suita, Osaka 565-0871, Japan.

Dendi K Nugraha (DK)

Department of Molecular Bacteriology, Research Institute for Microbial Diseases, Osaka University, Suita, Osaka 565-0871, Japan.

Yasuhiko Horiguchi (Y)

Department of Molecular Bacteriology, Research Institute for Microbial Diseases, Osaka University, Suita, Osaka 565-0871, Japan.
Center for Infectious Disease Education and Research, Osaka University, Suita, Osaka 565-0871, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH